Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2
- 期刊名称Open Forum Infectious Diseases
- 作者Rockstroh, Jürgen K; Orkin, Chloe; Viani, Rolando M; Wyles, David; Luetkemeyer, Anne F; Lazzarin, Adriano; Soto-Malave, Ruth; Nelson, Mark R; Bhagani, Sanjay R; Klinker, Hartwig H F; Rizzardini, Giuliano; Girard, Pierre-Marie; Tural, Cristina; Shulman, Nancy S; Mobashery, Niloufar; Hu, Yiran B; Fredrick, Linda M; Pilot-Matias, Tami; Trinh, Roger; Gane, Edward
- 卷第4卷
- 期第3期
- 电子ISSN2328-8957
- 文件大小332.56KB
- 发表时间2017-07-01
- DOI10.1093/ofid/ofx154
FDA Regulatory Affairs, Third Edition || The Practice of Regulatory AffairsPisano, Douglas; Mantus, David · 2014
Medical Product Regulatory Affairs || Regulatory StrategyTobin, John J.; Walsh, Gary · 2008
Regulatory Affairs 101: Introduction to Expedited Regulatory PathwaysCox, Erica M.; Edmund, Anita V.; Kratz, Erica; Lockwood, Sarah H.; Shankar, Aishwarya · Clinical and Translational Science · 2020
Good laboratory practices and other regulatory issues: A regulatory affairs viewMildred S. Christian · 1995
Good regulatory practice and the role(s) of a regulatory affairs professionalGoebel-Lauth, Susanne · Medical Writing · 2013
FDA Regulatory Affairs, Third Edition || Overview of the GxPs for the Regulatory ProfessionalPisano, Douglas; Mantus, David · 2014
Handbook of Medical Device Regulatory Affairs in Asia || United States Medical Device Regulatory FrameworkTong, Raymond · 2013
Handbook of Medical Device Regulatory Affairs in Asia || The Evolution of the Regulatory ProfessionalTong, Raymond · 2013